Market Performance of Maxcyte (MXCT)
Trading session ending 12:48 AM Central Europe, Friday 23 October 2026
- Closing price: USD 1.43
- Price change: Up 2.8 % in the 24‑hour period.
- Volume traded: USD 2.1 million.
- Shares outstanding: 103.2 million.
- Market capitalization: USD 147.6 million.
- Year‑to‑date performance: Up 18.55 % since the end of the previous month.
- 200‑day simple moving average: USD 1.06.
- 52‑week high: USD 1.80 on 19 November 2025.
- 52‑week low: USD 0.64 on 17 February 2026.
Comparison with Peer Stocks (last 24 hours)
| Stock | Ticker | Change | Current Price (USD) | Market Cap (USD million) | P/E Ratio |
|---|---|---|---|---|---|
| Energy Services Of America | ESEO | +0.21 % | 9.14 | 174.8 | 22.32 |
| Vera Bradley | VRA | +0.83 % | 6.12 | 172.7 | – |
| Triplepoint Venture Growth B | TPVG | –1.40 % | 4.30 | 174.6 | 4.41 |
| Shutterstock | SSTK | –1.08 % | 4.73 | 170.3 | – |
| Akebia Therapeutics | AKBA | –5.34 % | 0.56 | 171.3 | – |
Company Overview
MaxCyte, Inc. is headquartered in Gaithersburg, Maryland, United States. The company specializes in biotechnology services for laboratory testing and research. Its product portfolio includes processing assemblies, protein production, cell analysis, and antibody research.
